Publication dates

All regions

Cancer Industry, July 2014 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, prostate cancer, more »


 
1-20 of about 141 000 reports for Cancer

Leukemia Drug Pipeline Update 2014

Leukemia Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Referenced for the presence of mutations associated with human cancer. To date 265 out of the 269 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow ...

Bladder Cancer Drug Pipeline Update 2014

Bladder Cancer Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

... Bladder cancer drug pipeline update 2014 according to the american cancer society, bladder cancer is the 6th most common cancer in the u.S. Bladder cancer occurs among both men and women. When found ...

Brain Cancer Drug Pipeline Update 2014

Brain Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Number of ceased drugs over the last years amount to another 82 drugs. Brain cancer drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked ...

Breast Cancer Drug Pipeline Update 2014

Breast Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... According to type of indication from drop-down menu in the application.Targetsmutationsall targets are cross-referenced with the catalogue of somatic mutations in cancer (cosmic ...

Cancer Vaccines Drug Pipeline Update 2014

Cancer Vaccines Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... cancer. To date 137 out of the 140 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational ...

Colorectal Cancer Drug Pipeline Update 2014

Colorectal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... And the accumulated number of ceased drugs over the last years amount to another 182 drugs. Colorectal cancer drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...

Head and Neck Cancer Drug Pipeline Update 2014

Head and Neck Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... And the accumulated number of ceased drugs over the last years amount to another 48 drugs. Head and neck cancer drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified ...

Hematological Cancers Drug Pipeline Update 2014

Hematological Cancers Drug Pipeline Update 2014

  • $ 2 999
  • Industry report
  • July 2014
  • by Bioseeker

... Different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 380 out of the 385 studied drug targets so far have been recorded ...

Liver Cancer Drug Pipeline Update 2014

Liver Cancer Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

... And the accumulated number of ceased drugs over the last years amount to another 56 drugs. Liver cancer drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...

Lung Cancer Drug Pipeline Update 2014

Lung Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... With human cancer. To date 319 out of the 322 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out ...

About 23 000 reports for Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Cancer Statistics, 2013
  • January 2013
    20 pages
  • Cancer  

  • United States  

    North America  

View report >

81 Companies for Cancer

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Cepheid

United States

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.